Alan B. Lancz & Associates, Inc. Baxter International Inc Transaction History
Alan B. Lancz & Associates, Inc.
- $98.1 Million
- Q2 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 8,250 shares of BAX stock, worth $190,822. This represents 0.25% of its overall portfolio holdings.
Number of Shares
8,250
Previous 8,250
-0.0%
Holding current value
$190,822
Previous $282,000
11.7%
% of portfolio
0.25%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding BAX
# of Institutions
902Shares Held
479MCall Options Held
3.64MPut Options Held
1.52M-
Black Rock Inc. New York, NY63MShares$1.46 Billion0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA62.2MShares$1.44 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA52.1MShares$1.21 Billion0.95% of portfolio
-
Richard Pzena Pzena Investment Management LLC39.3MShares$910 Million3.99% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22MShares$508 Million0.08% of portfolio
About BAXTER INTERNATIONAL INC
- Ticker BAX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 504,120,992
- Market Cap $11.7B
- Description
- Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...